Lot documentation is pending
We show no result for this exact configuration while its lot-specific report is unavailable.
Browse the COA library
Purity:99.9% by HPLC
Best seller 
Package image for the selected configuration.
GLP-3 (RT) 10 mg
A triple glucagon, GIP, and GLP-1 receptor agonist research peptide in exact 10 mg and 30 mg configurations.
Available to verified research accountsExact-SKU documentationLaboratory research use only
The U.S. Food and Drug Administration has not evaluated statements on this site. Stack Research products are not intended to diagnose, treat, cure, or prevent any disease or medical condition.
Lab results for the selected configuration
The published laboratory report covers this exact lot.
- Exact SKU
- STK-RT10
- Lot
- 1032
- Laboratory
- Accumark Labs
- Report ID
- VMGN-S9MH
- Sample received
- 2026-06-11
- Published
- June 23, 2026
IdentityConforms
HPLC purity99.9% by HPLC
Measured content10.37 mg measured
Bacterial endotoxinPass
SterilityNot detected
Read the complete laboratory report
Open full report
Open the PDF to read every page in the lot-specific report.
Documentation is pending for this exact SKU
We show no purity, identity, content, or contaminant result until a lot-specific report is available.
About GLP-3 (RT)
The linked discovery and early clinical papers use the designation LY3437943 and describe agonist activity at glucagon, GIP, and GLP-1 receptors. They cover the researchers' own test articles and do not establish the composition or performance of this product.
Stack Research supplies this product only for lawful in-vitro laboratory or analytical research. The independent literature linked on this page does not test this vial, and it provides no instructions for human or veterinary use.
Configuration and documentation
The configuration selected above controls the exact SKU, package image, and lot report shown on this page.
Research-use boundary
This page does not provide dosing, administration, treatment, diagnostic, or human-outcome guidance.
Product specifications
- Available configurations
- 10 mg / 30 mg
- Physical form
- Lyophilized powder
- Composition
- Triple agonist research peptide
- Molecular formula
- C223H343F3N46O70
- CAS number
- 2381089-83-2
- Documentation
- Lot-specific COA published for this exact SKU.
Research & literature
The publications below cover triple GLP-1, GIP, and glucagon receptor agonist research. Only the lot report above evaluates the Stack Research product.
A paper's findings do not establish the identity, purity, safety, or intended use of this product.
Search PubMed for GLP-3 (RT) (opens in a new tab)- LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Coskun T et al. · Cell Metabolism · 2022 PMID: 35985340 (opens in a new tab)
- LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial. Urva S et al. · The Lancet · 2022 PMID: 36354040 (opens in a new tab)
Mechanism & research background
The selected papers use the designation LY3437943 and describe agonist activity at glucagon, GIP, and GLP-1 receptors. The sources span discovery work and an early multiple-ascending-dose clinical trial.
The publications below cover triple GLP-1, GIP, and glucagon receptor agonist research. Only the lot report above evaluates the Stack Research product.
Researchers should read each linked paper for its model, methods, and limits. The cited literature does not supply instructions for this product.
Frequently asked questions
What does “triple agonist” refer to?
The linked LY3437943 papers describe agonist activity at glucagon, GIP, and GLP-1 receptors. This receptor profile is a literature topic, not a lot-specific test result.
Does LY3437943 literature verify GLP-3 (RT)?
No. The papers examine their own study materials. They do not establish this product's identity, purity, content, sterility, or performance.
Is a lot report available for the selected configuration?
A current lot report covers exact SKU STK-RT10, lot 1032, from Accumark Labs.
Does the selected configuration control the report shown?
Yes. Choosing a configuration updates every SKU-specific field and its linked lot report as one set.
Do the cited papers verify this vial?
No. The papers describe independent research. The lab-results section above contains the lot-specific evidence for this Stack Research product.
Do the studies cover the full GLP-3 (RT) formulation?
The publications below cover triple GLP-1, GIP, and glucagon receptor agonist research. Only the lot report above evaluates the Stack Research product.
Can this page guide human or veterinary use?
No. Stack Research supplies this product for laboratory research only. This page provides no dosing, administration, treatment, or diagnostic guidance.
Can researchers open the original sources?
Yes. Each citation opens its PubMed record. The search link above opens the complete product-specific query.
More to explore
Browse other products currently listed in the Stack Research catalog.
GLP-1 (SE)
Research peptides · 5 mg / 10 mg View product
GLP-2 (TZ)
Research peptides · 10 mg / 30 mg View product
BPC-157
Research peptides · 5 mg / 10 mg View product
TB-500
Research peptides · 10 mg View product
TA-1 (Thymosin Alpha-1)
Research peptides · 10 mg View product
Sermorelin
Research peptides · 5 mg View product
Tesamorelin
Research peptides · 10 mg View product
Ipamorelin
Research peptides · 5 mg View product
Need documentation for GLP-3 (RT)?
Send the exact SKU and lot so support can trace the applicable product record.